Direct Oral Anticoagulants or Vitamin K Antagonists after TAVR: Insights from the ENVISAGE-TAVI AF and ATLANTIS Trials.

Federico OliveriAndrea BongiornoLorenzo TuaClaudio MontaltoAlessandro FasolinoFrancesca Romana GentileAntonella PepeMarco FerliniStefano GhioSergio Leonardi

Published in: Thrombosis and haemostasis (2022)

Keyphrases

direct oral anticoagulants
atrial fibrillation
transcatheter aortic valve replacement
aortic valve
aortic stenosis
transcatheter aortic valve implantation
venous thromboembolism
ejection fraction
left ventricular
heart failure
coronary artery disease